Loss of kinase activity in Mycobacterium tuberculosis multidomain protein Rv1364c

Preeti Sachdeva1, Azeet Narayan, Richa Misra

  • 1Institute of Genomics and Integrative Biology (CSIR), Delhi, India.

The FEBS Journal
|November 20, 2008
PubMed

Insights

Researchers identified a novel protein in Mycobacterium tuberculosis that integrates the entire regulatory pathway for sigma factor F (SigF). This protein, Rv1364c, and another, UsfX, show a loss of kinase activity, potentially explaining SigF regulation in this pathogen.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Alternative sigma factors are crucial for bacterial gene regulation, controlled by complex phosphorylation cascades.
  • In Mycobacterium tuberculosis, the regulation of sigma factor F (SigF) involves anti-SigF and anti-anti-SigF proteins, but the kinases and phosphatases remain elusive.
  • Understanding these regulatory mechanisms is vital for deciphering bacterial adaptation and pathogenesis.

Purpose of the Study:

  • To identify and characterize the missing phosphorylation-dephosphorylation factors in the Mycobacterium tuberculosis SigF regulatory pathway.
  • To investigate the novel multidomain protein Rv1364c as a potential integrated regulator of SigF.
  • To elucidate the kinase activity of Rv1364c and UsfX in the context of SigF regulation.

Main Methods:

  • Sequence analysis of the Mycobacterium tuberculosis Rv1364c protein to predict functional domains (phosphatase, anti-SigF, anti-anti-SigF).
  • Biochemical assays using purified Rv1364c (RsbW domain) and UsfX proteins.
  • Assessment of autophosphorylation, phosphotransfer capabilities, and binding affinity to ATP analogs.

Main Results:

  • Rv1364c integrates phosphatase (RsbU), anti-SigF (RsbW), and anti-anti-SigF (RsbV) domains within a single polypeptide.
  • The RsbW domain of Rv1364c and the UsfX protein exhibit significant substitutions and deletions, leading to a loss of kinase activity and impaired ATP binding.
  • Despite reduced kinase function, Rv1364c and UsfX retain functional interactions with cognate sigma and anti-anti-sigma factors.

Conclusions:

  • The identified loss of kinase activity in Rv1364c and UsfX represents a critical missing link in the phosphorylation-dependent regulation of SigF in Mycobacterium tuberculosis.
  • Rv1364c acts as a unique, species-specific multidomain protein that likely orchestrates the entire SigF signal transduction cascade.
  • These findings provide new insights into the intricate regulatory networks governing bacterial gene expression and adaptation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...